Interview with Philippe Ranty, Managing Director, Actavis France
Most players entered the generic pharmaceutical industry in France in the late 1990s into the 2000s yet Actavis decided to enter much later – in late 2007 – through an…
Address: 3, rue Joseph Monier, Rueil-Malmaison 92500 ,France
Tel: + 33 (0)1 58 83 60 00
With 30 000 employees and 50 subsidiaries, Bristol-Myers Squibb was up to the 11th largest pharmaceutical companies worldwide.
Aware of the expectations from healthcare professionals, patients and governments, BMS is mobilized around a clear strategy: to focus its research on therapeutic priority areas and improve the success rate at each stage of a process development, which spans over ten years.
Internally, an innovative personnel management style contributes to employee development. Externally, Bristol-Myers Squibb undertakes concrete actions to preserve the environment.
BMS FRANCE:
* 3100 employees
* 1st Group subsidiary outside the U.S.
* 7th company of the drug in France
* C.A. 2008: 1 billion €
Cardiovascular
Virology
Oncology
Pain
Neuroscience
Self-medication (OTC)
Most players entered the generic pharmaceutical industry in France in the late 1990s into the 2000s yet Actavis decided to enter much later – in late 2007 – through an…
CIP and GERS have very unique relationships with the pharmaceutical industry. Could you elaborate on the role of these two bodies? Club Inter-pharmaceutique (CIP) is a professional association created in…
As a majority of our readers are American that may be used to a different model of clusters can you explain the unique characteristics of the pôles de compétitivité? The…
Aricept has been a very effective blockbuster for the group as a whole and the loss of exclusivity affects not only France but entire company. How is Eisai in France…
There is a lot of change occurring in the French pharmaceutical industry at the moment and this is no different for Boehringer Ingelheim. Just last September you moved into these…
As president of LEEM, what will be your legacy and what legacy would you like to instill in the organization? A legacy of re-industrialization in the French pharmaceutical and health…
Roche has a long history in France and currently enjoys a higher position than its worldwide ranking. Can you elaborate on the importance of this market for the group overall?…
Do you feel the industry has changed more over the past ten years than over the entire 40 years before? It’s an optical illusion. People always have had the feelings…
As the G5 brings together five very different companies – Ipsen, LFB, Pierre Fabre, Sanofi-Aventis, Servier – could you explain the origin behind the creation and the purpose of the…
You’ve been at the head of AstraZeneca France for 7 years through during which time there has been a lot of M&A activity in the industry as well as a…
US pharmaceutical companies have long been in the French market but in your experience how do you feel they have integrated the differences in culture? Is this a finished topic…
Generic drugs were a very late arrival for the French market in comparison with other European markets and healthcare systems on a par with the French one. Today the gap…
See our Cookie Privacy Policy Here
